Access cutting-edge epidermolysis bullosa treatment through this phase 1/2 clinical trial at a research site in Redwood City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Redwood City location
Preparing your pre-screening questions…
Access epidermolysis bullosa specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related epidermolysis bullosa treatment provided free
Check if you qualify for this epidermolysis bullosa clinical trial in Redwood City, CA
No-Cost Study Care
Local to Redwood City
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The study objective is to see if IV IgG treatment in Recessive Dystrophic Epidermolysis Bullosa (RDEB) skin in conjunction with VYJUVEK treatment improves wound healing and affects the levels of C7 and HSV-1 antibody levels in serum. Fewer wounds, more rapidly healing wounds, and decreased C7 and HSV-1 antibodies could improve quality of life.
Sponsor: M. Peter Marinkovich
Yes, this clinical trial (NCT06834035) has an active research site in Redwood City, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for epidermolysis bullosa treatment options in Redwood City, CA, this clinical trial (NCT06834035) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Redwood City research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced epidermolysis bullosa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all epidermolysis bullosa clinical trials near you to find additional studies recruiting in your area.
See all sleep apnea clinical trials recruiting in Redwood City — not just this study.
Browse Sleep Apnea Trials in Redwood City →